Fattore J, training event at Johnson&Johnson's Milan headquarters
For its fifth edition, Fattore J, the project born from the collaboration with Johnson & Johnson Innovative Medicine Italia, strengthens its community: on one side students, their families, teachers, on the other side J&J employees, major health institutions and patient associations.
In particular, on the occasion ofWorld Cancer Day, 4 February 2025, J&J is organising two meetings (3 and 27 February) to take students on a journey of discovery, to discover what lies behindtherapeutic innovation and the value it brings to patients' lives.
During the meeting, Johnson&Johnson company experts share their experiences and knowledge with 60 students from high schools (Maria Immacolata of Gorgonzola, Falcone-Righi of Corsico, Oriani-Mazzini of Milan and Primo Levi of Bollate). The session is structured in such a way as to offer a combination of presentations, case studies and interactive question-and-answer sessions to enable all participants to explore the topics of interest in depth.
AGENDA
10.00 | Welcome greetings
Introduced and moderated by Gianpaolo Colletti, journalist for Il Sole24Ore
Video World cancer day
Speeches by
- Alessandra Baldini, Country Medical Affairs Director Johnson & Johnson Italy
- Elisa Amorelli, Communication and Social Marketing Coordinator
- Cristina Destro, Walce representative
10.20 | The phases of the drug journey by J&J experts
- Marika Bianco, Local Trial Manager - Johnson & Johnson Innovative Medicine
- Francesca Reversi, Sr Site Manager Johnson & Johnson Innovative Medicine
- Federica Resci, Senior Medical Affairs Manager Hematology at Johnson & Johnson Innovative Medicine
- Carmen Sansone, HEMAR Manager - Johnson & Johnson Innovative Medicine
- Alessandro Leonardo, Area Manager - Johnson & Johnson Innovative Medicine
- Federica Sala, Local safety Officer Back-up - Johnson & Johnson Innovative Medicine
- Giovanni Riccardi, Head of Data Analysis and Artificial Intelligence - Johnson & Johnson Innovative Medicine
11.00 | Student Q&A
11.15 | Conclusions
Interview with Alessandro Borriello, Commercial Director Oncology-Hematology at Johnson & Johnson Innovative Medicine
11.30 | Group photo
